The study, published in Nature yesterday, warns that the current generation of vaccines and monoclonal antibody treatments may lose the arms race against the coronavirus, raising the daunting, open-ended possibility of reinfection unless vaccine rollout is greatly expedited worldwide to prevent further mutations.
Read more on RT.